Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: EVRG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on EVRG, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 972,170 EVRG shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 972,170 shares
    Change vs previous 13F -11,218 shares

    1.54% of the 13F portfolio, value $84,024,653.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 983,388 shares
    Change vs previous 13F +34,155 shares

    1.55% of the 13F portfolio, value $80,559,145.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 949,233 shares
    Change vs previous 13F -9,122 shares

    1.44% of the 13F portfolio, value $68,815,059.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 958,355 shares
    Change vs previous 13F not available

    1.63% of the 13F portfolio, value $72,859,643.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).